The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy
Abstract
Ferroptosis is a recently discovered route of regulated cell death that offers the opportunities for the treatment of chemotherapy-resistant tumor indications, but its efficacy can be affected by the glutathione peroxidase 4 (GPX4) and ferroptosis suppressor protein 1 (FSP1) antioxidant mechanisms, posing significant challenges for its clinical translation. In this study, we report a Cu-tetra(4-carboxyphenyl)porphyrin chloride(Fe(III)) (Cu-TCPP(Fe)) metal organic framework (MOF)-based nanosystem for the efficient incorporation of Au nanoparticles (NPs) and RSL3, which can demonstrate enzyme-like activities to universally suppress the antiferroptotic pathways in tumor cells for amplifying ferroptotic damage. Herein, Cu-TCPP(Fe) MOF nanosheets were integrated with Au NPs via in situ nucleation and loaded with RSL3 via π–π stacking, which were eventually modified with polyethylene glycol (PEG) and iRGD for tumor-targeted drug delivery. Specifically, the Au NPs can demonstrate glucose oxidase-like activities for efficient glucose depletion, thus disrupting the pentose phosphate pathway to impede reduced glutathione (GSH) biosynthesis and prevent the recycling of coenzyme Q10 (CoQ10) to CoQ10H2, while Cu species can oxidize GSH into oxidized glutathione (GSSG). These nanocatalytic activities can lead to the simultaneous inhibition of the GPX4/GSH and FSP1/CoQ10H2 pathways and cooperate with the GPX4-deactivating function of RSL3 to cause pronounced ferroptotic damage, thereby providing a strong rationale for the application of ferroptosis therapy in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,505
Breast Cancer Treatment: A Review
Waks, A. G., & Winer, E. P. (2019) · JAMA · doi:10.1001/jama.2018.19323 · Cited by 4,804
Ferroptosis: molecular mechanisms and health implications
Tang, D., Chen, X., Kang, R., & Kroemer, G. (2021) · Cell Research · doi:10.1038/s41422-020-00441-1 · Cited by 4,256
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Bersuker, K., Hendricks, J. M., Li, Z., Magtanong, L., Ford, B., Tang, P. H., Roberts, M. A., Tong, B., Maimone, T. J., Zoncu, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1705-2 · Cited by 3,703
FSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E., & Gianni, L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.66 · Cited by 3,079
Targeting Ferroptosis to Iron Out Cancer
Hassannia, B., Vandenabeele, P., & Vanden Berghe, T. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.002 · Cited by 2,478
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis
Ingold, I., Berndt, C., Schmitt, S., Doll, S., Poschmann, G., Buday, K., Roveri, A., Peng, X., Porto Freitas, F., Seibt, T., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.048 · Cited by 1,656
The Metabolic Underpinnings of Ferroptosis
Zheng, J., & Conrad, M. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.011 · Cited by 1,329
Emerging Mechanisms and Disease Relevance of Ferroptosis
Stockwell, B. R., Jiang, X., & Gu, W. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.02.009 · Cited by 1,099
Zilka, O., Shah, R., Li, B., Friedmann Angeli, J. P., Griesser, M., Conrad, M., & Pratt, D. A. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00028 · Cited by 1,038
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Zhang, Y., Shi, J., Liu, X., Feng, L., Gong, Z., Koppula, P., Sirohi, K., Li, X., Wei, Y., Lee, H., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0178-0 · Cited by 1,013
Self-citationThe chemical basis of ferroptosis
Conrad, M., & Pratt, D. A. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0408-1 · Cited by 1,002
Insight into the mechanism of ferroptosis inhibition by ferrostatin-1
Miotto, G., Rossetto, M., Di Paolo, M. L., Orian, L., Venerando, R., Roveri, A., Vučković, A.-M., Bosello Travain, V., Zaccarin, M., Zennaro, L., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101328 · Cited by 906
Zhou, N., & Bao, J. (2020) · Database · doi:10.1093/database/baaa021 · Cited by 788
Xu, J., Xu, L., Wang, C., Yang, R., Zhuang, Q., Han, X., Dong, Z., Zhu, W., Peng, R., & Liu, Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b00715 · Cited by 695
Self-Catalyzed, Self-Limiting Growth of Glucose Oxidase-Mimicking Gold Nanoparticles
Luo, W., Zhu, C., Su, S., Li, D., He, Y., Huang, Q., & Fan, C. (2010) · ACS Nano · doi:10.1021/nn102592h · Cited by 650
Self-citationCellular degradation systems in ferroptosis
Chen, X., Yu, C., Kang, R., Kroemer, G., & Tang, D. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00728-1 · Cited by 628
PEG Branched Polymer for Functionalization of Nanomaterials with Ultralong Blood Circulation
Prencipe, G., Tabakman, S. M., Welsher, K., Liu, Z., Goodwin, A. P., Zhang, L., Henry, J., & Dai, H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja809086q · Cited by 600
Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation
Zhu, P., Chen, Y., & Shi, J. (2018) · ACS Nano · doi:10.1021/acsnano.8b00999 · Cited by 572
2D Nanomaterials for Cancer Theranostic Applications
Cheng, L., Wang, X., Gong, F., Liu, T., & Liu, Z. (2020) · Advanced Materials · doi:10.1002/adma.201902333 · Cited by 569
Huang, Y., Zhao, M., Han, S., Lai, Z., Yang, J., Tan, C., Ma, Q., Lu, Q., Chen, J., Zhang, X., et al. (2017) · Advanced Materials · doi:10.1002/adma.201700102 · Cited by 487
Wang, C., Cao, F., Ruan, Y., Jia, X., Zhen, W., & Jiang, X. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201903981 · Cited by 411
Liu, C., Xing, J., Akakuru, O. U., Luo, L., Sun, S., Zou, R., Yu, Z., Fang, Q., & Wu, A. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02253 · Cited by 337
Xue, C.-C., Li, M.-H., Zhao, Y., Zhou, J., Hu, Y., Cai, K.-Y., Zhao, Y., Yu, S.-H., & Luo, Z. (2020) · Science Advances · doi:10.1126/sciadv.aax1346 · Cited by 299
Self-citationFumarate induces redox-dependent senescence by modifying glutathione metabolism
Zheng, L., Cardaci, S., Jerby, L., MacKenzie, E. D., Sciacovelli, M., Johnson, T. I., Gaude, E., King, A., Leach, J. D. G., Edrada-Ebel, R., et al. (2015) · Nature Communications · doi:10.1038/ncomms7001 · Cited by 281
Activatable Polymer Nanoenzymes for Photodynamic Immunometabolic Cancer Therapy
Zeng, Z., Zhang, C., Li, J., Cui, D., Jiang, Y., & Pu, K. (2021) · Advanced Materials · doi:10.1002/adma.202007247 · Cited by 276
miR-30-5p-mediated ferroptosis of trophoblasts is implicated in the pathogenesis of preeclampsia
Zhang, H., He, Y., Wang, J.-X., Chen, M.-H., Xu, J.-J., Jiang, M.-H., Feng, Y.-L., & Gu, Y.-F. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101402 · Cited by 248
Self-citationDing, Y., Xu, H., Xu, C., Tong, Z., Zhang, S., Bai, Y., Chen, Y., Xu, Q., Zhou, L., Ding, H., et al. (2020) · Advanced Science · doi:10.1002/advs.202001060 · Cited by 241
Triggered ferroptotic polymer micelles for reversing multidrug resistance to chemotherapy
Gao, M., Deng, J., Liu, F., Fan, A., Wang, Y., Wu, H., Ding, D., Kong, D., Wang, Z., Peer, D., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119486 · Cited by 218
Dai, L., Li, K., Li, M., Zhao, X., Luo, Z., Lu, L., Luo, Y., & Cai, K. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201707249 · Cited by 193
Self-citationLi, K., Lin, C., He, Y., Lu, L., Xu, K., Tao, B., Xia, Z., Zeng, R., Mao, Y., Luo, Z. Y., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c07071 · Cited by 155
Self-citationNanoenzymes in disease diagnosis and therapy
Yu, Z., Lou, R., Pan, W., Li, N., & Tang, B. (2020) · Chemical Communications · doi:10.1039/d0cc05427e · Cited by 154
iRGD Modified Chemo‐immunotherapeutic Nanoparticles for Enhanced Immunotherapy against Glioblastoma
Kuang, J., Song, W. L., Yin, J., Zeng, X., Han, S. H., Zhao, Y., Tao, J., Liu, C., He, X., & Zhang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201800025 · Cited by 133
Wu, T., Xue, L., Liu, X., Li, Y., Wang, Y., Kong, L., & Tang, M. (2020) · Particle and Fibre Toxicology · doi:10.1186/s12989-020-00363-1 · Cited by 132
Glucose deprivation induces mitochondrial dysfunction and oxidative stress in PC12 cell line
Liu, Y., Song, X., Liu, W., Zhang, T., & Zuo, J. (2003) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2003.tb00202.x · Cited by 131
Synergistic substrate cofeeding stimulates reductive metabolism
Park, J. O., Liu, N., Holinski, K. M., Emerson, D. F., Qiao, K., Woolston, B. M., Xu, J., Lazar, Z., Islam, M. A., Vidoudez, C., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0077-0 · Cited by 118
Li, K., Lu, L., Xue, C., Liu, J., He, Y., Zhou, J., Xia, Z., Dai, L., Luo, Z. Y., Mao, Y., et al. (2019) · Nanoscale · doi:10.1039/c9nr06505a · Cited by 117
Self-citationZhu, W., Yang, Y. P., Jin, Q., Chao, Y., Tian, L., Liu, J., Dong, Z., & Liu, Z. (2018) · Nano Research · doi:10.1007/s12274-018-2242-2 · Cited by 105
Zheng, Q., Li, P., Zhou, X., Qiang, Y., Fan, J., Lin, Y., Chen, Y., Guo, J., Wang, F., Xue, H., et al. (2021) · Theranostics · doi:10.7150/thno.60233 · Cited by 101
An, Y., Zhu, J., Liu, F., Deng, J., Meng, X., Liu, G., Wu, H., Fan, A., Wang, Z., & Zhao, Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10954 · Cited by 95
Interventions to Improve Oral Chemotherapy Safety and Quality: A Systematic Review
Zerillo, J. A., Goldenberg, B. A., Kotecha, R. R., Tewari, A. K., Jacobson, J. O., & Krzyzanowska, M. K. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0625 · Cited by 90
Tumor-penetrating therapy for β5 integrin-rich pancreas cancer
de Mendoza, T. H., Mose, E. S., Botta, G. P., Braun, G. B., Kotamraju, V. R., French, R. P., Suzuki, K., Miyamura, N., Teesalu, T., Ruoslahti, E. I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21858-1 · Cited by 89
Song, C., Li, Y., Li, T., Yang, Y., Huang, Z., de la Fuente, J. M., Ni, J., & Cui, D. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201906309 · Cited by 85
Is Nanostructuring Sufficient To Get Catalytically Active Au?
Klyushin, A. Y., Greiner, M. T., Huang, X., Lunkenbein, T., Li, X., Timpe, O., Friedrich, M., Hävecker, M., Knop‐Gericke, A., & Schlögl, R. (2016) · ACS Catalysis · doi:10.1021/acscatal.5b02631 · Cited by 82
Self-citationDai, L., Zhang, Q., Li, J., Shen, X., Mu, C., & Cai, K. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b00746 · Cited by 81
Self-citationTargeting prominin2 transcription to overcome ferroptosis resistance in cancer
Brown, C. W., Chhoy, P., Mukhopadhyay, D., Karner, E. R., & Mercurio, A. M. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013792 · Cited by 75
Moon, S. J., Dong, W., Stephanopoulos, G. N., & Sikes, H. D. (2020) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10184 · Cited by 72
β-Cyclodextrin conjugated magnetic nanoparticles for diazepam removal from blood
Cai, K., Li, J., Luo, Z. Y., Hu, Y., Hou, Y., & Ding, X. (2011) · Chemical Communications · doi:10.1039/c1cc11855b · Cited by 71
Self-citationEngineering of a Core–Shell Nanoplatform to Overcome Multidrug Resistance via ATP Deprivation
Liu, G., Wang, L., Liu, J., Lu, L., Mo, D., Li, K., Yang, X. H., Zeng, R., Zhang, J., Liu, P., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000432 · Cited by 38
Self-citationGlucose Oxidase and Horseradish Peroxidase Like Activities of Cuprous Oxide/Polypyrrole Composites
Periasamy, A. P., Roy, P., Wu, W., Huang, Y., & Chang, H. (2016) · Electrochimica Acta · doi:10.1016/j.electacta.2016.08.071 · Cited by 34
Cited by
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Sun, S., Shen, J., Jiang, J., Wang, F., & Min, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01606-1 · Cited by 608
Li, F.-J., Long, H.-Z., Zhou, Z.-W., Luo, H.-Y., Xu, S.-G., & Gao, L.-C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.910292 · Cited by 438
FSP1: a key regulator of ferroptosis
Li, W., Liang, L., Liu, S., Yi, H., & Zhou, Y. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.05.013 · Cited by 287
Ferroptosis: principles and significance in health and disease
Chen, F., Kang, R., Tang, D., & Liu, J. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01564-3 · Cited by 285
RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer
Xu, Z., Wang, X., Sun, W., Xu, F., Kou, H., Hu, W., Zhang, Y., Jiang, Q., Tang, J., & Xu, Y. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102952 · Cited by 76
Metadata
- Authors
- Li, K., Lin, C., Li, M., Xu, K., He, Y., Mao, Y., Lu, L., Geng, W., Li, X., Luo, Z., & Cai, K.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-01-18
- Volume
- 16
- Issue
- 2
- Pages
- 2381-2398
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W4205154707
- Cited by
- 262
- References
- 53
- FWCI
- 15.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.